In Vitro Safety Pharmacology Profiling of Topical α-Adrenergic Agonist Treatments for Erythema of Rosacea

BACKGROUND: Topical α-adrenergic agonist therapy has been developed to treat the persistent erythema of rosacea patients. Brimonidine and oxymetazoline are both topical α-adrenergic agonists. OBJECTIVES: The objective of this in vitro safety pharmacology study was to compare the potential safety pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Piwnica, David, Pathak, Atul, Schäfer, Gregor, Docherty, James R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833911/
https://www.ncbi.nlm.nih.gov/pubmed/29374829
http://dx.doi.org/10.1007/s40268-018-0227-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833911/
https://www.ncbi.nlm.nih.gov/pubmed/29374829
http://dx.doi.org/10.1007/s40268-018-0227-y

Ejemplares similares